» Articles » PMID: 20514280

Montelukast Protects Against Testes Ischemia/reperfusion Injury in Rats

Overview
Specialty Urology
Date 2010 Jun 2
PMID 20514280
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: In this study, we investigate the effect of montelukast on histologic damage induced by testicular torsion-detorsion in rats.

Methods: Twenty-one male Sprague-Dawley rats were separated into 3 groups, each containing 7 rats. A sham operation was performed in group 1 (control). In group 2 (ischemia-reperfusion [IR]/untreated), 1-hour detorsion of the testis was performed after 6 hours of unilateral testicular torsion. In group 3 (I-R/dextroamphetamine), after performing the same surgical procedures as in group 2, montelukast was given intraperitoneally. In all experimental rats, ipsilateral orchiectomies were performed for histological examination and tissue malondialdehyde (MDA), glutathione and myeloperoxidase assays.

Results: Montelukast treatment significantly decreased the I-R-induced elevation in testes tissue MDA and glutathione levels were found to be preserved. The level of myeloperoxidase (MPO) activity was significantly increased in the testes tissue of the IR/untreated group. However, in I-R/montelukast treatment group significantly decreased testes tissue MPO level. Histopathologically, the in the group 2 rats, edema, congestion, hemorrhage between seminiferous tubules and necrosis of the germinal cells were predominant features in sections. However, most of the specimens in the montelukast treated group 3 showed grades-I and II injury. Additionally, the testicular injury score was lower in group 3 rats compared with group 2.

Conclusion: The current findings demonstrate that the montelukast decreased the severity of testicular injury by reversing the oxidative effects of testes I-R.

Citing Articles

Critique and recommendations for an experimental study.

Dagli S Hepatol Forum. 2022; 3(2):66-67.

PMID: 35783477 PMC: 9243759. DOI: 10.14744/hf.2022.2022.0009.


Montelukast for Medical Delay in Flap Surgery.

Iranpour M, Khodarahmi A, Khodarahmi N, Shafiee M, Malekpourafshar R, Nakhaee N World J Plast Surg. 2020; 9(1):48-54.

PMID: 32190592 PMC: 7068180. DOI: 10.29252/wjps.9.1.48.


Effect of etoricoxib on experimental oxidative testicular ischemia-reperfusion damage in rats induced with torsion-detorsion.

Yapanoglu T, Ozkaya F, Yilmaz A, Mammadov R, Cimen F, Hirik E Korean J Physiol Pharmacol. 2017; 21(5):457-464.

PMID: 28883750 PMC: 5587596. DOI: 10.4196/kjpp.2017.21.5.457.


The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.

Hoxha M, Rovati G, Bueno Cavanillas A Eur J Clin Pharmacol. 2017; 73(7):799-809.

PMID: 28374082 DOI: 10.1007/s00228-017-2242-2.


Montelukast prevents testes against ischemia-reperfusion injury through suppression of iNOS expression.

Silay M, Toklu H, Ozagari A, Aydin M, Tetik S, Sener G Turk J Urol. 2015; 40(4):221-7.

PMID: 26328182 PMC: 4548366. DOI: 10.5152/tud.2014.61587.


References
1.
Buege J, Aust S . Microsomal lipid peroxidation. Methods Enzymol. 1978; 52:302-10. DOI: 10.1016/s0076-6879(78)52032-6. View

2.
Ross D . Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. Pharmacol Ther. 1988; 37(2):231-49. DOI: 10.1016/0163-7258(88)90027-7. View

3.
Ishikawa F, Miyazaki S . New biodefense strategies by neutrophils. Arch Immunol Ther Exp (Warsz). 2005; 53(3):226-33. View

4.
FISCH H, Laor E, Reid R, Tolia B, Freed S . Gonadal dysfunction after testicular torsion: luteinizing hormone and follicle-stimulating hormone response to gonadotropin releasing hormone. J Urol. 1988; 139(5):961-4. DOI: 10.1016/s0022-5347(17)42731-5. View

5.
Bozlu M, Coskun B, Cayan S, Acar D, Aktas S, Ulusoy E . Inhibition of poly(adenosine diphosphate-ribose) polymerase decreases long-term histologic damage in testicular ischemia-reperfusion injury. Urology. 2004; 63(4):791-5. DOI: 10.1016/j.urology.2003.10.062. View